Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 6/2014

01-06-2014 | Literatur kommentiert

Ist eine D2- gegenüber einer D1-Lymphknotendissektion für Patienten mit Magenkarzinom von Vorteil?

Author: PD Dr. Thomas B. Brunner

Published in: Strahlentherapie und Onkologie | Issue 6/2014

Login to get access

Auszug

Degiuli M, Sasako M, Ponti A et al (2014) Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 101:23–31 …
Literature
1.
Maruyama K, Okabayashi K, Kinoshita T (1987) Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 11:418–425PubMedCrossRef
2.
Bonenkamp JJ, Songun I, Hermans J et al (1995) Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345:745–748PubMedCrossRef
3.
Cuschieri A, Fayers P, Fielding J et al (1996) Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 347:995–999PubMedCrossRef
4.
Degiuli M, Sasako M, Ponti A et al (2014) Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer. Br J Surg 101:23–31PubMedCrossRef
5.
Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725–730PubMedCrossRef
6.
Wu CW, Hsiung CA, Lo SS et al (2006) Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 7:309–315PubMedCrossRef
Metadata
Title
Ist eine D2- gegenüber einer D1-Lymphknotendissektion für Patienten mit Magenkarzinom von Vorteil?
Author
PD Dr. Thomas B. Brunner
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 6/2014
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-014-0623-3

Other articles of this Issue 6/2014

Strahlentherapie und Onkologie 6/2014 Go to the issue

Nachruf

Zum Gedenken an Professor Dr. György Nemeth (1935–2014)

Letter to the Editors

Is radiation an effective therapy in echinococcus multilocularis?

Original article

Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer

Original article

Stereotactic radiosurgery for treatment of brain metastases

Original article

Influence of experience and qualification on PET-based target volume delineation

Literatur kommentiert

Niedrigdosis-Chemotherapie hoch wirksam bei Erwachsenen mit sporadischem oder HIV-assoziiertem Burkitt-Lymphom